Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2012

View Archived Issues

Radius Health scientists design novel SARMs

Roche presents new potential products to treat/prevent CMV infection

Biota Holdings presents novel antibacterials

Interferon-free combination therapy shows promise to treat chronic hepatitis C

Encouraging phase I data reported on candidate arthritis immunotherapy

Pretargeted radioimmunotherapy is safe, specific and fast in patients with colorectal tumors

Korean team discovers novel serum biomarker of ovarian carcinoma

Genocea Biosciences presents potential HSV-2 vaccine at ongoing conference

Proteostasis Therapeutics to collaborate with CFFT

Interim data reported from combination study in CF

Sunovion confirms upcoming availability of ciclesonide nasal aerosol

Iluvien gains U.K. marketing authorization

Aeterna Zentaris regains rights to perifosine

Galleon Pharmaceuticals reports phase I GAL-021 study results

FDA clears p53 image analysis algorithm

Alder BioPharmaceuticals launches phase I trial of mAb for migraine

German BfArM issues recommendation on Pliaglis MAA

Santen and Bayer Yakuhin enter copromotion agreement

First-in-human data disclosed on topical RNAi drug for ocular pain

New phase III study of Adcetris begins

Immunomic Therapeutics clear to launch phase I trial of Japanese red cedar allergy vaccine

New candidate drugs for tuberculosis designed at GSK

Investigation at Roche yields novel TWEAK-specific antibodies

Envoy Therapeutics receives second grant from Michael J. Fox Foundation

FDA extends PDUFA date for Marqibo NDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...